echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Dongyang Sunshine Subsidiary Received Drug Registration Certificate for Escitalopram Oxalate Tablets

    Dongyang Sunshine Subsidiary Received Drug Registration Certificate for Escitalopram Oxalate Tablets

    • Last Update: 2021-05-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On April 20, Dongyang Sunshine issued an announcement stating that its holding subsidiary, Dongguan Yangzhikang Pharmaceutical Co.


    Escitalopram is used to treat depression and is a single dextrorotatory optical isomer of citalopram, a bicyclic hydrogen phthalate derivative.


    Escitalopram is a category A product in the 2020 edition of the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List, and it is also a category in the 2018 edition of the National Essential Drug List.


    The product is escitalopram, one of the 27 generic drugs purchased by Yichang Dongyang Yangtze Pharmaceutical Co.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.